Chelsea Counsel Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-80
Closed -$12.9K 151
2022
Q4
$12.9K Buy
+80
New +$12.9K 0.01% 144
2022
Q3
Sell
-1,700
Closed -$260K 82
2022
Q2
$260K Hold
1,700
0.13% 87
2022
Q1
$276K Hold
1,700
0.12% 86
2021
Q4
$230K Buy
+1,700
New +$230K 0.1% 93
2018
Q3
Sell
-2,280
Closed -$211K 77
2018
Q2
$211K Sell
2,280
-100
-4% -$9.25K 0.13% 74
2018
Q1
$225K Hold
2,380
0.14% 64
2017
Q4
$230K Hold
2,380
0.12% 75
2017
Q3
$211K Sell
2,380
-800
-25% -$70.9K 0.11% 77
2017
Q2
$231K Hold
3,180
0.12% 74
2017
Q1
$207K Sell
3,180
-831
-21% -$54.1K 0.11% 77
2016
Q4
$251K Hold
4,011
0.13% 80
2016
Q3
$253K Sell
4,011
-751
-16% -$47.4K 0.13% 83
2016
Q2
$295K Hold
4,762
0.13% 85
2016
Q1
$272K Hold
4,762
0.09% 109
2015
Q4
$282K Sell
4,762
-2,831
-37% -$168K 0.09% 115
2015
Q3
$413K Sell
7,593
-1
-0% -$54 0.1% 101
2015
Q2
$510K Buy
7,594
+1,363
+22% +$91.5K 0.11% 85
2015
Q1
$365K Hold
6,231
0.08% 99
2014
Q4
$408K Buy
6,231
+415
+7% +$27.2K 0.08% 93
2014
Q3
$336K Sell
5,816
-171,159
-97% -$9.89M 0.07% 100
2014
Q2
$9.99M Buy
176,975
+1,500
+0.9% +$84.7K 1.95% 21
2014
Q1
$9.02M Buy
175,475
+1,806
+1% +$92.8K 1.83% 22
2013
Q4
$9.17M Sell
173,669
-9,243
-5% -$488K 2.17% 19
2013
Q3
$8.18M Buy
182,912
+355
+0.2% +$15.9K 1.7% 25
2013
Q2
$7.55M Buy
+182,557
New +$7.55M 1.98% 22